Global Targeted RNA Sequencing Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Targeted RNA Sequencing Market
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

In the report, we only collect information about the companies who can provide targeted RNA sequencing service.

The global Targeted RNA Sequencing market size is projected to reach US$ 7570 million by 2028, from US$ 1800.6 million in 2021, at a CAGR of 22.5% during 2022-2028.

Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.

North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Targeted RNA Sequencing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Targeted RNA Sequencing market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Targeted RNA Sequencing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Targeted RNA Sequencing market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Targeted RNA Sequencing market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Targeted RNA Sequencing Breakdown Data by Type

Exome Sequencing

Enrichment Sequencing

Amplicon Sequencing

Targeted RNA Sequencing Breakdown Data by Application

Research Institutes

Hospitals & Clinics

Biotechnology Company

Diagnostic Lab

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Thermo Fisher

Illumina

Roche Holdings

BGI

Eurofins

LabCorp

Berry Genomics

Macrogen

GENEWIZ

TABLE OF CONTENT

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Targeted RNA Sequencing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Exome Sequencing

1.2.3 Enrichment Sequencing

1.2.4 Amplicon Sequencing

1.3 Market by Application

1.3.1 Global Targeted RNA Sequencing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Research Institutes

1.3.3 Hospitals & Clinics

1.3.4 Biotechnology Company

1.3.5 Diagnostic Lab

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Targeted RNA Sequencing Market Perspective (2017-2028)

2.2 Targeted RNA Sequencing Growth Trends by Region

2.2.1 Targeted RNA Sequencing Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Targeted RNA Sequencing Historic Market Size by Region (2017-2022)

2.2.3 Targeted RNA Sequencing Forecasted Market Size by Region (2023-2028)

2.3 Targeted RNA Sequencing Market Dynamics

2.3.1 Targeted RNA Sequencing Industry Trends

2.3.2 Targeted RNA Sequencing Market Drivers

2.3.3 Targeted RNA Sequencing Market Challenges

2.3.4 Targeted RNA Sequencing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Targeted RNA Sequencing Players by Revenue

3.1.1 Global Top Targeted RNA Sequencing Players by Revenue (2017-2022)

3.1.2 Global Targeted RNA Sequencing Revenue Market Share by Players (2017-2022)

3.2 Global Targeted RNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Targeted RNA Sequencing Revenue

3.4 Global Targeted RNA Sequencing Market Concentration Ratio

3.4.1 Global Targeted RNA Sequencing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Targeted RNA Sequencing Revenue in 2021

3.5 Targeted RNA Sequencing Key Players Head office and Area Served

3.6 Key Players Targeted RNA Sequencing Product Solution and Service

3.7 Date of Enter into Targeted RNA Sequencing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted RNA Sequencing Breakdown Data by Type

4.1 Global Targeted RNA Sequencing Historic Market Size by Type (2017-2022)

4.2 Global Targeted RNA Sequencing Forecasted Market Size by Type (2023-2028)

5 Targeted RNA Sequencing Breakdown Data by Application

5.1 Global Targeted RNA Sequencing Historic Market Size by Application (2017-2022)

5.2 Global Targeted RNA Sequencing Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Targeted RNA Sequencing Market Size (2017-2028)

6.2 North America Targeted RNA Sequencing Market Size by Type

6.2.1 North America Targeted RNA Sequencing Market Size by Type (2017-2022)

6.2.2 North America Targeted RNA Sequencing Market Size by Type (2023-2028)

6.2.3 North America Targeted RNA Sequencing Market Share by Type (2017-2028)

6.3 North America Targeted RNA Sequencing Market Size by Application

6.3.1 North America Targeted RNA Sequencing Market Size by Application (2017-2022)

6.3.2 North America Targeted RNA Sequencing Market Size by Application (2023-2028)

6.3.3 North America Targeted RNA Sequencing Market Share by Application (2017-2028)

6.4 North America Targeted RNA Sequencing Market Size by Country

6.4.1 North America Targeted RNA Sequencing Market Size by Country (2017-2022)

6.4.2 North America Targeted RNA Sequencing Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Targeted RNA Sequencing Market Size (2017-2028)

7.2 Europe Targeted RNA Sequencing Market Size by Type

7.2.1 Europe Targeted RNA Sequencing Market Size by Type (2017-2022)

7.2.2 Europe Targeted RNA Sequencing Market Size by Type (2023-2028)

7.2.3 Europe Targeted RNA Sequencing Market Share by Type (2017-2028)

7.3 Europe Targeted RNA Sequencing Market Size by Application

7.3.1 Europe Targeted RNA Sequencing Market Size by Application (2017-2022)

7.3.2 Europe Targeted RNA Sequencing Market Size by Application (2023-2028)

7.3.3 Europe Targeted RNA Sequencing Market Share by Application (2017-2028)

7.4 Europe Targeted RNA Sequencing Market Size by Country

7.4.1 Europe Targeted RNA Sequencing Market Size by Country (2017-2022)

7.4.2 Europe Targeted RNA Sequencing Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Targeted RNA Sequencing Market Size (2017-2028)

8.2 Asia-Pacific Targeted RNA Sequencing Market Size by Type

8.2.1 Asia-Pacific Targeted RNA Sequencing Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Targeted RNA Sequencing Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Targeted RNA Sequencing Market Share by Type (2017-2028)

8.3 Asia-Pacific Targeted RNA Sequencing Market Size by Application

8.3.1 Asia-Pacific Targeted RNA Sequencing Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Targeted RNA Sequencing Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Targeted RNA Sequencing Market Share by Application (2017-2028)

8.4 Asia-Pacific Targeted RNA Sequencing Market Size by Region

8.4.1 Asia-Pacific Targeted RNA Sequencing Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Targeted RNA Sequencing Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Targeted RNA Sequencing Market Size (2017-2028)

9.2 Latin America Targeted RNA Sequencing Market Size by Type

9.2.1 Latin America Targeted RNA Sequencing Market Size by Type (2017-2022)

9.2.2 Latin America Targeted RNA Sequencing Market Size by Type (2023-2028)

9.2.3 Latin America Targeted RNA Sequencing Market Share by Type (2017-2028)

9.3 Latin America Targeted RNA Sequencing Market Size by Application

9.3.1 Latin America Targeted RNA Sequencing Market Size by Application (2017-2022)

9.3.2 Latin America Targeted RNA Sequencing Market Size by Application (2023-2028)

9.3.3 Latin America Targeted RNA Sequencing Market Share by Application (2017-2028)

9.4 Latin America Targeted RNA Sequencing Market Size by Country

9.4.1 Latin America Targeted RNA Sequencing Market Size by Country (2017-2022)

9.4.2 Latin America Targeted RNA Sequencing Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Targeted RNA Sequencing Market Size (2017-2028)

10.2 Middle East & Africa Targeted RNA Sequencing Market Size by Type

10.2.1 Middle East & Africa Targeted RNA Sequencing Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Targeted RNA Sequencing Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Targeted RNA Sequencing Market Share by Type (2017-2028)

10.3 Middle East & Africa Targeted RNA Sequencing Market Size by Application

10.3.1 Middle East & Africa Targeted RNA Sequencing Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Targeted RNA Sequencing Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Targeted RNA Sequencing Market Share by Application (2017-2028)

10.4 Middle East & Africa Targeted RNA Sequencing Market Size by Country

10.4.1 Middle East & Africa Targeted RNA Sequencing Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Targeted RNA Sequencing Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Thermo Fisher

11.1.1 Thermo Fisher Company Details

11.1.2 Thermo Fisher Business Overview

11.1.3 Thermo Fisher Targeted RNA Sequencing Introduction

11.1.4 Thermo Fisher Revenue in Targeted RNA Sequencing Business (2017-2022)

11.1.5 Thermo Fisher Recent Developments

11.2 Illumina

11.2.1 Illumina Company Details

11.2.2 Illumina Business Overview

11.2.3 Illumina Targeted RNA Sequencing Introduction

11.2.4 Illumina Revenue in Targeted RNA Sequencing Business (2017-2022)

11.2.5 Illumina Recent Developments

11.3 Roche Holdings

11.3.1 Roche Holdings Company Details

11.3.2 Roche Holdings Business Overview

11.3.3 Roche Holdings Targeted RNA Sequencing Introduction

11.3.4 Roche Holdings Revenue in Targeted RNA Sequencing Business (2017-2022)

11.3.5 Roche Holdings Recent Developments

11.4 BGI

11.4.1 BGI Company Details

11.4.2 BGI Business Overview

11.4.3 BGI Targeted RNA Sequencing Introduction

11.4.4 BGI Revenue in Targeted RNA Sequencing Business (2017-2022)

11.4.5 BGI Recent Developments

11.5 Eurofins

11.5.1 Eurofins Company Details

11.5.2 Eurofins Business Overview

11.5.3 Eurofins Targeted RNA Sequencing Introduction

11.5.4 Eurofins Revenue in Targeted RNA Sequencing Business (2017-2022)

11.5.5 Eurofins Recent Developments

11.6 LabCorp

11.6.1 LabCorp Company Details

11.6.2 LabCorp Business Overview

11.6.3 LabCorp Targeted RNA Sequencing Introduction

11.6.4 LabCorp Revenue in Targeted RNA Sequencing Business (2017-2022)

11.6.5 LabCorp Recent Developments

11.7 Berry Genomics

11.7.1 Berry Genomics Company Details

11.7.2 Berry Genomics Business Overview

11.7.3 Berry Genomics Targeted RNA Sequencing Introduction

11.7.4 Berry Genomics Revenue in Targeted RNA Sequencing Business (2017-2022)

11.7.5 Berry Genomics Recent Developments

11.8 Macrogen

11.8.1 Macrogen Company Details

11.8.2 Macrogen Business Overview

11.8.3 Macrogen Targeted RNA Sequencing Introduction

11.8.4 Macrogen Revenue in Targeted RNA Sequencing Business (2017-2022)

11.8.5 Macrogen Recent Developments

11.9 GENEWIZ

11.9.1 GENEWIZ Company Details

11.9.2 GENEWIZ Business Overview

11.9.3 GENEWIZ Targeted RNA Sequencing Introduction

11.9.4 GENEWIZ Revenue in Targeted RNA Sequencing Business (2017-2022)

11.9.5 GENEWIZ Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

Choose License Type

Checkout Inquiry Sample